View of Efficacy and Safety of Low-Dose Ipragliflozin, a Selective Sodium Glucose Transporter 2 Inhibitor, in Patients with Type 2 Diabetes Mellitus

Address: Prof. Dr. N. Sriram, Editor & Publisher, Peerzadiguda, Hyderabad-500 098, India.
Email: ijamscr@gmail.com | Phone: +91 9704361947

This journal is published under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.